KYTX

News Kyverna Therapeutics appoints Greg Martini as CFO

15d ago

SEC filing KYTX Appoints Nadia Dac as CCO, 30Y Exp, Launches miv-cel for Stiff Person Syndrome, $300K Inducement Option

29d ago

News Kyverna rises on new mid-stage trial data for myasthenia gravis therapy

43d ago

News Byrna anticipates continued margin expansion and 2,000-store footprint growth in 2026 as new products launch

116d ago

Scanner Large move: down 32.5% (2.0x typical daily range)

165d ago

News Kyverna Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock

166d ago

Scanner Unusual volume (z=72.1)

168d ago

News Kyverna Therapeutics Announces Proposed Public Offering of Common Stock

169d ago

Scanner Unusual volume (z=3.2)

169d ago

Scanner Unusual volume (z=3.2)

170d ago

Scanner Unusual volume (z=3.2)

171d ago